NKX3.1
Jump to navigation
Jump to search
NKX3.1 is a relatively new immunostain for prostate cancer.
Positive
Rarely positive
- Invasive ductal carcinoma of the breast ~2% of cases.[2]
- Invasive lobular carcinoma ~10% of cases.[2]
See also
References
- ↑ Gordetsky, J.; Epstein, JI. (Jul 2014). "Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.". Am J Surg Pathol 38 (7): 941-5. doi:10.1097/PAS.0000000000000178. PMID 24503758.
- ↑ 2.0 2.1 Asch-Kendrick, RJ.; Samols, MA.; Lilo, MT.; Subhawong, AP.; Sharma, R.; Illei, PB.; Argani, P.; Cimino-Mathews, A. (Sep 2014). "NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.". J Clin Pathol 67 (9): 768-71. doi:10.1136/jclinpath-2014-202272. PMID 24996432.